Starting off the week with the beat of pre-market stocks – a rousing spectacle of jubilant gainers and downtrodden losers.

Stellar Gainers:

1. Kidpik (NASDAQ: PIK) leads the way, with shares soaring a colossal 270% amidst frenzied pre-market trading.
2. Fangdd Network (NASDAQ: DUO) is a star performer, rising nearly 105% as it sets its sights on the real estate stock asset services sector.
3. Auddia (NASDAQ: AUUD) blazes a trail with a powerful surge of over 54%, dominating the early morning trades.
4. HeartCore Enterprises (NASDAQ: HTCR) defies the odds, up by a remarkable 34% despite a conspicuous absence of news.
5. Mesoblast (NASDAQ: MESO) elevates itself by almost 21% following a significant update from the FDA.
6. AirNet Technology (NASDAQ: ANTE) takes flight, propelling shares 20% higher post the announcement of board of directors changes.
7. Graphite Bio (NASDAQ: GRPH) shines bright with an 18% surge, bolstered by a special dividend announcement tied to a proposed merger.
8. GDS Holdings (NASDAQ: GDS) jumps over 18% on rumors of potential new investments beckoning on the horizon.
9. TC BioPharm (NASDAQ: TCBP) ascends by nearly 17%, orchestrating a lively performance with heavy trading volumes.
10. NuScale Power (NYSE: SMR) electrifies the stage, up by over 14% after announcing its participation in upcoming investor conferences.

Noteworthy Losers:

1. Semilux International (NASDAQ: SELX) nosedives dramatically by more than 22%, following a spirited rally on Friday.
2. DHC Acquisition (NASDAQ: DHCA) plunges over 21% as it edges towards a merger culmination.
3. Psyence Biomedical (NASDAQ: PBM) endures a harsh decline of nearly 19% after a recent rally.
4. Lytus Technologies (NASDAQ: LYT) slips down by more than 17% post recent media appearances.
5. Addex Therapeutics (NASDAQ: ADXN) stumbles over a 16% drop despite the absence of significant news.
6. Avenue Therapeutics (NASDAQ: ATXI) tumbles more than 16% amid plans for a reverse stock split.
7. CERo Therapeutics (NASDAQ: CERO) wanes over 15% after a sudden surge in price on the previous trading day.
8. Mira Pharmaceuticals (NASDAQ: MIRA) retreats by more than 15% following a recent bullish run.
9. Barnes & Noble Education (NYSE: BNED) sees a sharp dip of almost 15% amidst doubts raised about its financial continuity as a going concern.
10. XBP Europe (NASDAQ: XBP) wraps up the pre-market turmoil with a downward slide of over 14%.